Eyelid lesions are more often than not benign. Accurate diagnosis by an ophthalmologist is based on history and clinical examination. When in doubt, any suspicious lesion should undergo biopsy. Here we offer a brief review of some of the more common eyelid lesions that an ophthalmologist may encounter in a general practice. Background, ExamTo diagnose eyelid lesions one must first understand the anatomy of the eyelid and especially the eyelid margin and its characteristics. The eyelid margin consists of the skin, muscle, fat, tarsus, conjunctiva and adnexal structures including the approximately 100 eyelashes, glands of Zeis, glands of Moll, meibomian glands and the associated vascular and lymphatic supply. The examination of an eyelid lesion begins with history. History should include chronicity, symptoms (tenderness, change in vision, discharge), and evolution of the lesion. Other pertinent points include a history of skin cancer, immunosuppression, fair skin or radiation therapy. Physical examination should include assessment of
location, the appearance of the surface of the lesion and surrounding skin including adnexal structures. The clinician should be
assessing for any ulceration with crusting or bleeding, irregular pigment, loss of normal eyelid architecture, pearly edges with central ulceration, fine telangiectasia or loss of cutaneous wrinkles. Finally, a physical examination of the patient should include palpation of the edges and/or fixation to deeper tissues, and assessment of regional lymph nodes and the function of cranial nerves II-VII. A picture can be priceless for following disease progression or response to treatment. Although experienced clinicians may feel comfortable in their diagnosis, any doubt in clinical judgment should push the clinician for a histologic examination. Reports of clinically accurate diagnoses ranged from 83.7 percent to 96.9 percent with between 2 percent and 4.6 percent thought to be clinically benign but found to be histologically malignant.1,2ClassificationAmong tumors encountered by
ophthalmologist the most common neoplasms are those of the eyelid. Benign lesions of the eyelid represent upwards of 80 percent of eyelid neoplasms, while malignant tumors account for the remaining, with basal cell cancer the most frequent malignant tumor.3 It can be helpful to categorize eyelid lesions into inflammatory, infectious and neoplastic.
|Figure 1. Multiple chalazia located in the right lower lid of a 74-year-old female. They were treated with incision and drainage, and the biopsy was consistent with chalazion.
• Chalazion presents as chronic, localized swelling of the eyelid and typically affects the meibomian glands or glands of Zeis (See Figure 1). Data on the frequencies is difficult to come by, but in one recent review chalazia represented nearly half of all eyelid lesions encountered in an ophthalmology practice.3 Conservative treatment with warm compresses or topical steroids is often sufficient. Surgical management includes transconjunctival incision and curettage. If excision is performed it is recommended that histopathologic confirmation of the excised lesion be performed every time.1 Alternatively, management with intralesional triamcinolone can be used although this approach carries with it complications of pigment changes or more devastating central retinal artery embolization. Intralesional dexamethasone is a safer alternative.
• Molluscum contagiosum presents as pale, waxy and nodular cysts, classically with central umbilication. The patient is typically young, although there is increased incidence with more exuberant cases seen in AIDS patients due to reduced T cell count. They form secondary to infection from a DNA poxvirus and can present as a follicular conjunctivitis or lid nodules. The lid lesions may be misdiagnosed as a number of other eyelid lesions including basal cell carcinoma, papilloma, chalazion and sebaceous cyst. There is no predilection for the upper or lower eyelid and the local immune response will often be sufficient to eliminate the virus. Other treatment options include excision, cryotherapy or curettage.4
Neoplastic Lesions, Benign
• Squamous cell papillomas are formed from proliferation of epidermis and present either pedunculated, broad-based or white and hyperkeratotic lesions forming fingerlike projections.5 Treatment is usually not required except for cosmetic removal.
| Table 1. Malignant Eyelid Lesions Demographics and Risk Factors
| Basal Cell3,12
|| Lower, medial canthus
||Caucasians of Celtic ancestry
||Fair skin, sun exposure, smoking
| Squamous Cell3,12
||Caucasians and Asians
||Fair skin, sun exposure, exposure to radiation
| Sebaceous Gland3,14
|| Cancer syndromes and
| Merkel Cell3,10
|| Upper slightly
|| Systemic cancer
|| No predilection
|| Systemic lymphoma
|| Sun exposure
• Epidermal inclusion cysts present as elevated, smooth and progressively growing cysts that arise from entrapment of epidermal tissue in the dermis. Rupture with release of keratin can cause an inflammatory foreign-body reaction.6Treatment involves excision with retention of the surrounding capsule, simply decapitating the head of the cyst allowing granulation tissue to form.
• Acquired melanocytic nevi are frequently molded to the eyelid margin and represent clumps of melanocytes at the epidermis and dermis. Not clinically apparent at birth, they increase in pigmentation at puberty. In the second decade they tend to present as elevated, pigmented papules. Later, the superficial pigmentation is lost, and an elevated, but amelanotic lesion remains.6 They usually require no treatment, but malignant transformation of a junctional or compound nevus can rarely occur and requires excision.
• Seborrheic keratosis is an acquired benign condition affecting elderly patients. Classically the lesions have a greasy and stuck-on appearance with varying degrees of pigmentation. Excision is sometimes required but recurrence is quite high.
• Hidrocystoma, also known as sweat ductal cysts, are caused by blockage of a sweat duct. They present as small (average of 4 mm) soft, smooth and transparent lesions.5,7 Eccrine hidrocystoma often present as multiple cysts along the eyelids but do not involve the eyelid margin. Apocrine hidrocystomas characteristically transilluminate, involve the eyelid margin, and are associated with a hair follicle. The apocrine variety also tend to have a bluish color with yellow deposits. Cystic basal cell carcinoma is in the differential and specimens should be sent to pathology.
• Xanthelasmas present as yellowish plaques, usually in the medial canthal areas of either the upper or lower eyelids. The plaques are filled with lipid-laden macrophages. Patients usually have normal serum cholesterol levels but it is prudent to check lipid levels, as they can be associated with hypercholesterolemia.6 Treatment options include superficial excision, CO2 laser ablation or topical 100% trichloroacetic acid.
|Figure 2. Basal cell carcinoma of the left lower lid in a 57-year-old male. Note the pearly edges and central scab. Initial biopsy was consistent with BCC. The condition is treated with Mohs’ surgery with reconstruction with a Hughes flap by an oculoplastic specialist.
Neoplastic Lesions, Premalignant
• Actinic keratosis presents as round, scaly, hyper-keratotic plaques that have the texture of sandpaper. They are the most common precancerous skin lesion and usually affect elderly persons with fair complexion and excessive sun exposure. Malignant transformation for a single plaque is less than 1 percent per year.6 Observation is an option, but excisional biopsy is usually recommended to establish a diagnosis. Multiple lesions can be treated with cryotherapy, imiquimod 5% cream or other newer topical agents.
• Keratoacanthoma presents as flesh-colored papules usually on the lower eyelid in patients with chronic sun exposure or immunocompromised patients. This is now considered a low-grade squamous cell carcinoma in which dome-shaped hyperkeratotic lesions develop and can grow rapidly, with involution and regression at up to one year, once a keratin-filled crater develops.8 After diagnosis with incisional biopsy has been made, current recommendations include complete surgical excision.6
• Basal cell carcinoma represents 80 to 92.2 percent of malignant neoplasms in the periocular region.9 The localized nodular subtype is the “classic” lesion and presents most frequently on the lower lid at the medial canthus as a firm, raised, pearly nodules with fine telangiectasias (See Figure 2).11 A less common form of BCC, but more locally aggressive is the morpheaform type; these lesions lack ulceration, and appear as an indurated white to yellow plaque with indistinct margins.8
Patients are typically middle-aged or older and often fair-skinned, although it can occur in children and persons of African ancestry.12 BCC in younger patients has a more aggressive growth pattern and does not demonstrate the latency period seen in older patients.12 Treatment is primarily with Mohs’ micrographic surgery followed by eyelid/facial repair with oculoplastics.
Orbital invasion occurs in less than 5 percent of BCC and most commonly the lesions are at the medial canthus.8,12 Signs of orbital invasion include a fixed orbital mass, restrictive strabismus and globe displacement or destruction.9 CT or MRI is indicated to determine the extent of the disease. Once penetration reaches deep to the septum, local excision is very difficult. Nests of basal cells often hide, and this leads to more aggressive surgery (including orbital exenteration). Some cancer centers prefer external beam radiation followed by surgical removal in these advanced cases.
• Squamous cell carcinoma is the second most common eyelid malignancy, occurring in the lower lid approximately 60 percent of the time.13 SCC lacks the pathognomonic features, which allows for differentiation from precursor lesions including actinic keratosis, Bowen’s disease (squamous cell cancer in situ) and radiation dermatitis.8,12 The presentation is often with a painless nodular lesion with irregular rolled edges, pearly borders, telangiectasias and central ulceration, similar to BCC.12 The clinical diagnosis has been reported to be accurate anywhere from 51 percent to 62.7 percent of the time.13 Patients are generally males older than 60 and often have a history of other skin lesions requiring excision.11
Predisposing factors include both extrinsic factors, such as ultraviolet light, exposure to arsenic/hydrocarbons/radiation, HPV infection or immunosuppressive drugs and burns; and intrinsic factors of albinism and xeroderma pigmentosa.11,13 Metastasis of the lesions is most commonly through the lymphatic system, and early detection of lymph node involvement is essential to improve the prognosis.9,11SCC invades along the trigeminal, oculomotor and facial nerves and can present as asymptomatic perineural invasion detected on histologic examination or symptomatic perineural invasion. SCC with perineural invasion has a recurrence rate of up to 50 percent, and postoperative radiotherapy for all SCC with perineural invasion has been suggested.9
• Sebaceous carcinoma originates in the meibomian glands or the glands of Zeis and presents clinically as yellowish discoloration due to its lipid content; it can mimic blepharoconjunctivitis, chronic chalazia, BCC, SCC or other tumors (See Figure 3).8 The lesions most commonly affect women aged 65 to 70 in along the upper lid.14 It can present as loss of eyelashes, destruction of Meibomian orifices or chronic unilateral blepharoconjunctivitis. SC affects all races, but Asians in particular, and represents the most common or second most common periocular malignancy in this group.3,9
The diagnosis can be missed on initial biopsy, and may require multiple biopsies or special stains. Superficial biopsy is often not sufficient and can miss the underlying tumor; therefore a pentagonal full-thickness excision or punch biopsy may be necessary to make the diagnosis. Biopsy specimens with intraepithelial involvement of the conjunctiva should raise the suspicion for orbital invasion.8
|Figure 3. Sebaceous carcinoma of the left lower lid in a 52-year-old female. Patient presented with chronic unilateral blepharoconjunctivitis for 12 months, madarosis and eyelid lesion. Incisional biopsy showed sebaceous gland carcinoma. Definitive treatment should be undertaken by an experienced oculoplastic specialist or multidisciplinary team.
Although the etiology is not usually known, there is an association with Muir-Torre syndrome, an autosomal dominant cancer syndrome thought to be a subtype of hereditary nonpolyposis colorectal cancer. If SC is identified the patient should be evaluated for this syndrome.11 Mortality rates within industrialized countries have fallen to 9 to 15 percent; poor prognostic factors include duration longer than six months; vascular and lymphatic involvement; orbital extension; multicentric origin; intraepithelial carcinoma or pagetoid spread into the conjunctiva, cornea, or skin; upper lid location; and previous radiation.14
• Merkel cell carcinoma of the eyelid presents in elderly Caucasian women, average age of 75, with immunosuppression being a risk factor. Half of all MCCs are located in the head and neck, and between 5 and 10 percent occur in the eyelids.10 MCC presents in the upper lid as a painless, red-purple vascularized nodule, sparing of the overlying epidermis. In 20 to 60 percent of patients, there is lymph-node positivity at presentation and distant metastases appear within two years 70 percent of the time.15 This can be an aggressive, fatal cancer that requires judicious biopsy and systemic management by oncology.
Tumor size and metastasis at presentation are the most important prognostic factor with MCC tumors. The evaluation for tumor-lymph node-metastasis starts after the histologic diagnosis. Regarding treatment, the tumor responds well to radiation therapy, but primary treatment of the tumor is with excision and wide margins or Mohs’ surgery.10
• Metastasis to the eyelid is rare and represents less than 1 percent of malignant eyelid tumors; it usually occurs in the course of widespread metastatic disease, but can be the presenting sign of systemic cancer. The features of metastasis to the eyelid are not specific and can be solitary or multiple eyelid nodules or diffuse eyelid swelling. Biopsy should always be considered. Breast and cutaneous melanoma are the most common primary carcinomas.16
• Lymphomas of the ocular adnexa are primary tumors involving the orbit. Lymphoma presenting on the eyelid is rare and usually associated with systemic disease. Lymphoma of the eyelid represents 10 percent of ocular adnexal lymphoma.17
• Melanoma of the eyelid is a relatively rare tumor, making up less than 1 percent of eyelid cancers.5Lesions present in a patient in the sixth to eighth decade of life as a pigmented and thickened area of pigment on the lower eyelid with irregular borders.10,18 In any patient with a pigmented lesion, biopsy should be considered. REVIEW
Dr. Notz is a staff associate in ophthalmology at Geisinger Health System. Contact him at 100 North Academy Ave. Department of Ophthalmology, Danville, PA 17822. E-mail: firstname.lastname@example.org. Dr. Kasenchak is a second-year ophthalmology resident at Geisinger. E-mail: email@example.com.
A Retrospective Review of 1349 Cases of Sebaceous Carcinoma Tina Dasgupta, MD, PhD, Lynn D. Wilson, MD, MPH, and James B. Yu, MD
BACKGROUND. Sebaceous carcinoma is a rare and aggressive cutaneous carcinoma. It is believed that this malignancy predominates in the periocular region and occurs more frequently in Asian populations and in women. The objective of the current study was to analyze demographic characteristics and outcomes for patients with this malignancy from a large United States-based population registry. METHODS. An analysis of the National Cancer Institute’s Surveillance, Epidemiology, and End Results database from 1973 through 2004 was performed. RESULTS. Of 1349 patients who were identified, 54% were men, 86.2% were white, and 5.5% were of Asian/Pacific Islander ancestry. The median age at diagnosis was 73 years. The most frequent site of disease was the eyelid (38.7%). The population-matched 5- and 10-year age-matched relative survival rate was 91.9% (standard error [SE], 1.9%) and 79.2% (SE, 3.7%), respectively. Cause of death was attributable to cancer in 31% of patients. Orbital involvement did not predict for worsened survival compared with nonorbital involvement (5-year overall survival, 75.2% vs 68%, respectively; P ¼ .66). The overall population-matched rate of sebaceous carcinoma was highest in whites (2.03 cases per 1000,000; SE, 0.08) versus Asian/Pacific Islanders (1.07 per 1000,000; SE, 0.18; P ¼ .0001) versus blacks (0.48 per 1000,000; SE, 0.11; P < .0001). CONCLUSIONS. The current results support the finding of a predominance of men among patients with sebaceous carcinoma, and no difference was observed in the prognosis for orbital and periorbital involvement. This retrospective analysis also corroborated previous case reports of a higher incidence among patients with advanced age and the highest incidence for sites in the eyelid and skin of the face. The results also established that Asian/Pacific Islander ancestry is not a risk factor for developing sebaceous carcinoma. Cancer 2009;115:158–65. VC 2008 American Cancer Society. KEY WORDS: sebaceous carcinoma, SEER, Asian/Pacific Islanders, skin cancer.
Therefore, our results indicate that being of Asian/Pacific Islander ancestry is not a risk factor for sebaceous carcinoma.